Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma

MLA

Du, Ting, et al. “Ubiquitin Receptor PSMD4/Rpn10 Is a Novel Therapeutic Target in Multiple Myeloma.” Blood, vol. 141, no. 21, May 2023, pp. 2599–614. EBSCOhost, https://doi.org/10.1182/blood.2022017897.

APA

Du, T., Song, Y., Ray, A., Wan, X., Yao, Y., Samur, M. K., Shen, C., Penailillo, J., Sewastianik, T., Tai, Y.-T., Fulciniti, M., Munshi, N. C., Wu, H., Carrasco, R. D., Chauhan, D., & Anderson, K. C. (2023). Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma. Blood, 141(21), 2599–2614. https://doi.org/10.1182/blood.2022017897

Chicago

Du, Ting, Yan Song, Arghya Ray, Xueping Wan, Yao Yao, Mehmet K. Samur, Chen Shen, et al. 2023. “Ubiquitin Receptor PSMD4/Rpn10 Is a Novel Therapeutic Target in Multiple Myeloma.” Blood 141 (21): 2599–2614. doi:10.1182/blood.2022017897.